Ferring Degarelix Prostate Cancer Drug To Launch In First Quarter
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approves the gonadotropin-releasing hormone receptor antagonist, which hasn’t shown the initial surge in testosterone seen with other therapies.